Krsnaa Diagnostics: Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year
Krsnaa Diagnostics Ltd, one of India's fastest-growing integrated diagnostic service providers, announced its results for the nine months and quarter ending December 31, 2025. The company reported a 9% YoY increase in revenue, a 13% YoY increase in EBITDA, and a 5% YoY increase in PAT. The quarter saw a focus on improving working capital efficiency and accelerating recovery of long-pending government receivables, resulting in cash recoveries of over 3130 crore. The Rajasthan Pathology Project, despite front-loaded investments, is progressing as planned with meaningful revenue expected from the next financial year. The B2C segment is building strong momentum, contributing to sustainable growth, profitability, and long-term shareholder value.
Key Highlights
- Revenue for 9MFY2026 stood at 5,802 mn, a 9% YoY increase.
- EBITDA for 9MFY2026 was 1,600 mn, a 13% YoY increase.
- Profit After Tax (PAT) for 9MFY2026 was 597 mn, a 5% YoY increase.
- Cash recoveries of over 3130 crore during Q3.
- Revenue from the Rajasthan Pathology Project expected from the next financial year.